GlassScriptPhysician profile
Thatcher Allred
NPI 1760100085
$748.38
in general payments reported to CMS, 2019-2025
20 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $41.31 · 2023: $357 · 2024: $193 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $707.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $101.28 | 2023-2024 | Jardiance |
| Pfizer INC. | $77.41 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $70.92 | 2023-2025 | Spravato |
| Novo Nordisk INC | $55.04 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Organon LLC | $48.67 | 2023-2025 | Nexplanon |
| Novartis Pharmaceuticals Corporation | $40.48 | 2023-2024 | |
| Dynavax Technologies Corporation | $38.07 | 2023-2025 | Heplisav-B |
| Merck Sharp & Dohme LLC | $37.92 | 2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sobi, INC | $36.15 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $34.00 | 2023 | Flumist Quadrivalent |
| Ucb, INC. | $27.86 | 2022 | |
| Amgen INC. | $26.82 | 2024 | Otezla, Repatha |
| Abbvie INC. | $22.17 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.65 | 2025 | |
| Sanofi Pasteur INC. | $20.58 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.87 | 2025 | Dexcom G6 Transmitter |
| Cranial Technologies, INC | $19.86 | 2025 | Doc Band |
| Baxter Healthcare | $18.44 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Modernatx, INC. | $16.22 | 2023 | Moderna Covid-19 Vaccine |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.97 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thatcher Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.